Kenya’s health authorities have begun administering lenacapavir, a long-acting HIV prevention drug delivered by injection that offers protection for six months. The treatment will be available free of charge to eligible patients, making Kenya one of the first countries to introduce this new prevention therapy.
News24 | Trump administration to boost Afrikaner refugee numbers despite some delays
...
Read moreDetails
